Prehabilitation to Patients With Prostate Cancer

NCT ID: NCT07162987

Last Updated: 2025-09-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-04

Study Completion Date

2026-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this feasibility study is to test a newly developed, multicomponent prehabilitation intervention to patients with prostate cancer, to improve their resilience to treatment side-effects. The main questions it aims to answer are:

* Are patients and their close relatives willing to take part in prehabilitation?
* What is the acceptability and feasibility of the prehabilitation intervention, seen from the perspectives of patients, their close relatives, and healthcare professionals?
* Are the planned data collection methods feasible, and are there indications of a clinical effect?

Participants will:

* Take part in 12 weeks of physical exercise training
* Attend a 4-day residential prehabilitation intervention, where they receive education and do exercises. After 12 weeks, it is possible to take part in a voluntary follow-up session.
* Patients will respond to questionnaires about their health, symptoms, and quality of life. Patients and their close relatives will attend a group interview. Patients will also complete an exercise diary and brief physical tests

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostate Cancer (Diagnosis)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients receiving prehabilitation

The prehabilitation intervention includes: - Education about the disease and treatment - Physical exsercise training - Values in life - Energy preservation - Nutrition with a focus on hormone therapy - Identiy and role changes - Intimacy and sexuality - Sleep - Pelvic floor training - An individual session with a healthcare professional incl. goal setting

Group Type EXPERIMENTAL

Prehabilitation

Intervention Type BEHAVIORAL

Please refer to arm description

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Prehabilitation

Please refer to arm description

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with prostate cancer
* min 18 years old
* Treatment: Androgen deprivation therapy and raditation therapy
* Resident in Vejle Municipality or Esbjerg Municipality
* Can take part in residential prehabiliation in week 43 or 50, 2025, as well as physical exsercise training in the municipality
* Willing to take part in a research study
* Suited to take part in group sessions
* Be able to read and be understood in Danish
* Be responsible for own personal hygiene and medications at the 4-day residential stay
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

REHPA, The Danish Knowledge Centre for Rehabilitation and Palliative Care

OTHER

Sponsor Role collaborator

Vejle Hospital

OTHER

Sponsor Role collaborator

Esbjerg Municipality

OTHER_GOV

Sponsor Role collaborator

Esbjerg Hospital - University Hospital of Southern Denmark

OTHER

Sponsor Role collaborator

Odense University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Esbjerg Hospital

Esbjerg, Region Syddanmark, Denmark

Site Status RECRUITING

REHPA, the Danish Knowledge Centre for Rehabilitation and Palliative Care

Nyborg, Region Syddanmark, Denmark

Site Status RECRUITING

Vejle Hospital

Vejle, Region Syddanmark, Denmark

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Cecilie L Egholm, PhD

Role: primary

4529212232

Cecilie L Egholm, PhD

Role: primary

4529212232

Cecilie L Egholm, PhD

Role: primary

45 29 21 22 32

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

25/31257

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Preop Conformal Radiotherapy - Prostate
NCT00252447 COMPLETED PHASE1/PHASE2